NCT06285162

Brief Summary

The Analgesia Nociception Index (ANI) reflects the balance between sympathetic and parasympathetic tone. It is based on a specific interpretation of the R-R interval variation. During fluid removal by net ultrafiltration in patients with fluid overload and continuous renal replacement therapy, some data suggest that haemodynamic variation could be induced by the autonomic nervous system. The study aims to investigate ANI variations in this context and their association with the haemodynamic variations observed.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
11mo left

Started Jan 2026

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress27%
Jan 2026Apr 2027

First Submitted

Initial submission to the registry

February 22, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

February 29, 2024

Completed
1.9 years until next milestone

Study Start

First participant enrolled

January 9, 2026

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2027

Last Updated

January 15, 2026

Status Verified

January 1, 2026

Enrollment Period

1.2 years

First QC Date

February 22, 2024

Last Update Submit

January 14, 2026

Conditions

Keywords

Analgesia Nociception IndexR-R intervalautonomic nervous systemhaemodynamicfluid removal

Outcome Measures

Primary Outcomes (1)

  • Percentage of changes in ANI.

    Relative changes in ANI (averaged over 4 minutes (percentage)) between Hour 0 and Hour 6 of initiation of net ultrafiltration.

    6 hours after initiation of net ultrafiltration

Study Arms (1)

Critically ill patients with continuous renal replacement therapy.

The patients will be followed during the first 6 hours of the initiation of a net ultrafiltration (2-3 milliliters/kilograms/hour) with continuous monitoring (R-R interval, ANI, cardiac index, invasive arterial pressure, central venous pressure, peripheral perfusion index), and perfusion monitoring every 6 hours (arterial lactate, central venous oxygen saturation, capillary refill time, mottling score). Such a fluid removal strategy is part of an institutional protocol or an ongoing clinical trial. In addition to the usual monitoring, the PhysioDoloris monitor will be connected to the patient's scope. The ANI and its parameters will be recorded continuously throughout the study.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Critically ill patients with continuous renal replacement therapy, fluid overload and haemodynamically stable.

You may qualify if:

  • Continuous renal replacement therapy in intensive care unit
  • Initiation of net ultrafiltration according to the protocol of the department or to EARLYDRY study (NCT 05817539) (3 criteria required):
  • Fluid overload \> 5% or peripheral oedema
  • Noradrenaline equivalent \<0.5μg/kg/min
  • No peripheral hypoperfusion
  • Invasive blood pressure monitoring
  • Central venous line in superior vena cava territory
  • Regular sinus rhythm
  • Patient awake or Richmond Agitation and Sedation Scale \> -3

You may not qualify if:

  • Ongoing administration of inotropes
  • Ongoing administration of beta blockers
  • Current administration of alpha-2 agonists
  • History of dysautonomia
  • Pregnant or breast-feeding woman
  • Mechanical circulatory assistance
  • Opposition to participate
  • Adults under legal protection
  • Persons deprived of their liberty by judicial or administrative decision

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Département d'anesthésie-réanimation Hôpital cardiologique Louis Pradel

Bron, 69500, France

RECRUITING

MeSH Terms

Conditions

Critical Illness

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Martin RUSTE, MD

    Département d'anesthésie-réanimation, Hôpital cardiologique Louis Pradel, HCL

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 22, 2024

First Posted

February 29, 2024

Study Start

January 9, 2026

Primary Completion (Estimated)

April 1, 2027

Study Completion (Estimated)

April 1, 2027

Last Updated

January 15, 2026

Record last verified: 2026-01

Locations